Efficacy data was not collected or analyzed. This study did assess safety and tolerability of Xalatan.
- Patient with ocular hypertension at least 22mg Hg
- Patient must be over 18 years old
- None listed in the protocol
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: